Empowered Funds LLC Takes Position in Nutex Health Inc. $NUTX

Empowered Funds LLC purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 45,177 shares of the company’s stock, valued at approximately $7,720,000.

Several other institutional investors have also modified their holdings of NUTX. Bank of America Corp DE grew its position in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after buying an additional 2,043 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in Nutex Health by 17.9% in the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock valued at $852,000 after acquiring an additional 2,748 shares during the last quarter. Jane Street Group LLC purchased a new stake in Nutex Health in the first quarter valued at $522,000. JPMorgan Chase & Co. boosted its stake in Nutex Health by 41,430.0% in the second quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock valued at $1,034,000 after acquiring an additional 8,286 shares in the last quarter. Finally, Legal & General Group Plc acquired a new position in Nutex Health in the second quarter valued at $454,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Stock Performance

Shares of Nutex Health stock opened at $189.25 on Monday. The firm has a market cap of $1.30 billion, a price-to-earnings ratio of 7.43 and a beta of 0.24. Nutex Health Inc. has a 52-week low of $77.21 and a 52-week high of $204.00. The company’s 50-day simple moving average is $171.62 and its 200-day simple moving average is $133.84. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. The firm had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. As a group, equities research analysts anticipate that Nutex Health Inc. will post 30.11 earnings per share for the current year.

Wall Street Analyst Weigh In

NUTX has been the topic of several research analyst reports. Lake Street Capital reaffirmed a “buy” rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. B. Riley Financial assumed coverage on Nutex Health in a report on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective for the company. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Finally, Zacks Research raised shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average price target of $300.00.

Nutex Health Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.